TABLE 2.
Factors associated with 30-day all-cause case fatality due to Morganella morganii BSIs
| Factor | Data for patients who: |
P | ||
|---|---|---|---|---|
| Survived (n = 559) | Died (n = 150) | Overall (n = 709) | ||
| Age (median [IQR]) (yr) | 73.3 (62.6–82.0) | 79.7 (71.2–86.5) | 75.2 (64.2–83.0) | <0.0001 |
| Male sex (no. [%]) | 365 (65.3) | 98 (65.3) | 463 (65.3) | 0.5 |
| Infection onset (no. [%]) | 0.6 | |||
| Hospital | 156 (27.9) | 47 (31.3) | 203 (28.6) | |
| Community associated | 177 (31.7) | 49 (32.7) | 226 (31.9) | |
| Health care associated | 226 (40.4) | 54 (36.0) | 280 (39.5) | |
| Charlson score (median [IQR]) | 2 (1–4) | 4 (2–6) | 2 (1–5) | <0.0001 |
| Myocardial infarction (no. [%]) | 66 (11.8) | 23 (15.3) | 89 (12.6) | 0.2 |
| Congestive heart failure (no. [%]) | 118 (21.1) | 49 (32.7) | 167 (23.6) | 0.005 |
| Peripheral vascular disease (no. [%]) | 71 (12.7) | 27 (18.0) | 98 (13.8) | 0.1 |
| Cerebrovascular disease (no. [%]) | 46 (8.2) | 17 (11.3) | 63 (8.9) | 0.2 |
| Dementia (no. [%]) | 40 (7.2) | 23 (15.3) | 63 (8.9) | 0.003 |
| Chronic pulmonary disease (no. [%]) | 65 (11.6) | 25 (16.7) | 90 (12.7) | 0.1 |
| Rheumatic disease (no. [%]) | 15 (2.7) | 5 (3.3) | 20 (2.8) | 0.4 |
| Peptic ulcer disease (no. [%]) | 8 (1.4) | 5 (3.3) | 13 (1.8) | 0.2 |
| Liver disease (no. [%]) | 32 (5.7) | 9 (6.0) | 41 (5.8) | 0.8 |
| Diabetes mellitus (no. [%]) | 203 (36.3) | 47 (31.3) | 250 (35.3) | 0.3 |
| Plegia (no. [%]) | 43 (7.7) | 8 (5.3) | 51 (7.2) | 0.4 |
| Renal disease (no. [%]) | 155 (27.7) | 53 (35.3) | 208 (29.3) | 0.09 |
| Malignancy (no. [%]) | 91 (16.3) | 45 (30.0) | 136 (19.2) | <0.001 |
| Metastatic cancer (no. [%]) | 31 (5.6) | 23 (15.3) | 54 (7.6) | <0.001 |
| HIV positive (no. [%]) | 1 (0.2) | 0 | 1 (0.1) | 1 |
| Focus of infection (no. [%]) | 0.016 | |||
| No focus | 229 (41.4) | 89 (59.7) | 318 (45.3) | |
| Soft tissue | 109 (19.7) | 22 (14.8) | 131 (18.7) | |
| Bone and joint | 22 (4.0) | 3 (2.0) | 25 (3.6) | |
| Head and neck | 1 (0.2) | 0 | 1 (0.1) | |
| Lower respiratory tract | 28 (5.1) | 6 (4.0) | 34 (4.8) | |
| Endovascular | 5 (0.9) | 0 | 5 (0.7) | |
| Central nervous system | 1 (0.2) | 0 | 1 (0.1) | |
| Abdominal | 73 (13.2) | 17 (11.4) | 90 (12.8) | |
| Urinary/pelvic | 85 (15.4) | 12 (8.1) | 97 (3.8) | |
| Polymicrobial (no. [%]) | 185 (33.1) | 54 (36.0) | 239 (33.7) | 0.5 |
| Resistant (no. [%]) | 53 (9.5) | 14 (9.3) | 67 (9.5) | 1 |